Pharmacy benefits managers promote low-cost generics, adherence to drug plans

NewsGuard 100/100 Score

Pharmacy benefits managers have begun offering tools to help consumers find low-cost generic drugs, adhere to drug regimens and increase consumer choice, all of which can help increase profit margins, the Wall Street Journal reports.

According to the Journal, PBMs generally experience greater profit margins and members typically spend less when they use generic drugs, especially when ordered by mail. In addition, consumers who maintain their drug regimens help increase PBMs' revenues because they refill prescriptions more frequently. The Journal reports that promoting generic drugs and mail-order services has "helped benefits managers weather the soft economy better than many other health care concerns."

The Journal reports that Express Scripts is building an online program that allows the firm to customize marketing messages to members based on their profiles. The company also is attempting to convince more members to order prescriptions by mail rather than at brick and mortar pharmacies. According to Robert Nease, Express Scripts' chief scientist, moving patients who take maintenance medications -- such as those for diabetes, asthma or cholesterol -- to mail-order prescriptions is "good for everyone," including the consumer, the PBM and plan sponsors. After a generic version of the anti-cholesterol drug Zocor was introduced in mid-2006, Express Scripts combined financial incentives with "an advanced and aggressive communications program" that increased the ratio of consumers who used generic statin cholesterol drugs from 8% to 53.2% in March 2008. As a result of the campaign, plan sponsors and members reduced their spending by more than $600 million, according to Express Scripts.

Medco Health Solutions launched its online tool, My Rx Choices, in 2007, which offers consumers information about alternative drugs and costs at different pharmacies. About 4.5 million people have visited the site this year, according to Medco. The company also sends members mailings with information about lower-cost drug options and provides renewal reminders via e-mail and automated phone calls. According to Medco, patients could save hundreds of dollars each month by switching to lower-cost generics. Forrester Research in a report this year said My Rx Choices' use of "personas" for individual consumers is effective and drives "the kind of education and decision support that turns passive Rx takers into careful Rx shoppers."

CVS Caremark in May introduced "first fill counseling," in which pharmacists discuss new medications with patients. Helena Foulkes, senior vice president for health services at CVS Caremark, said one-third of consumers with new medications do not make the first refill but the counseling program has increased the number of consumers who do by 15%. According to the Journal, CVS hopes that by combining the resources of its retail pharmacy division with its PBM, it can increase business for both divisions and provide consumers advantages over competitors. The program also encourages adherence to drug regimens through mailings and phone calls (Wisenberg Brin, Wall Street Journal, 9/17).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds erectile dysfunction drugs linked to lower Alzheimer's risk